CodeBreaK300 Update HRQoL in mCRC sotorasib + panitumumab vs. T/T or regorafenib

OncologyTube: [00:00:00] Okay, here we are at ASCO GI 2024. We have Dominik Paul Modest, MD medical doctor from Charite,University of Medicine in Berlin. Dr. Modest, thank you so much for joining us today. You’re welcome. Today, we’ll be discussing health related quality of life in patients with metastatic colorectal cancer treated with sotorasib and … Continue reading CodeBreaK300 Update HRQoL in mCRC sotorasib + panitumumab vs. T/T or regorafenib